共 50 条
A new measure of multimorbid illness and treatment representations: The example of diabetes and depression
被引:4
|作者:
Mc Sharry, Jennifer
[1
]
Bishop, Felicity L.
[2
]
Moss-Morris, Rona
[3
]
Holt, Richard I. G.
[4
]
Kendrick, Tony
[5
]
机构:
[1] Natl Univ Ireland Galway, Sch Psychol, Hlth Behav Change Res Grp, Galway, Ireland
[2] Univ Southampton, Ctr Applicat Hlth Psychol, Southampton SO9 5NH, Hants, England
[3] Kings Coll London, Inst Psychiat, Dept Psychol, London WC2R 2LS, England
[4] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton SO9 5NH, Hants, England
[5] Univ Southampton, Southampton SO9 5NH, Hants, England
关键词:
Diabetes;
Depression;
Illness beliefs;
Multimorbidity;
Questionnaire;
Self-management;
HOSPITAL ANXIETY;
ASSOCIATION;
QUESTIONNAIRE;
PERCEPTIONS;
PEOPLE;
EPIDEMIOLOGY;
MANAGEMENT;
ADHERENCE;
VALIDITY;
BELIEFS;
D O I:
10.1016/j.jad.2014.11.050
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Background: Depression is two to three times more common in people with diabetes than in the general population. Although multimorbid diabetes and depression is associated with poor health outcome, existing research has focused on patients' understanding and management of each condition in isolation. This study describes the development and validation of the Diabetes and Depression Representation and Management Questionnaire (DDRMQ), a measure of understanding, management and medication beliefs in people with diabetes and depression. Methods: In Study 1, DDRMQ items were developed through further analysis of an earlier qualitative study and refined through 18 cognitive interviews. In Study 2, 334 adults with diabetes and depression from general practices, diabetes clinics and support groups completed the DDRMQ demographic questions and validating measures. Results: Factor analysis of the DDRMQ using principal axis factoring resulted in a 35 item scale organised into ten subscales. The modified measure had adequate internal and test-retest reliability. Initial evidence of construct validity was also demonstrated. Limitations: Low participant response rates and the high percentage of well-educated white participants limit the generalisability of results. As Study 2 was cross-sectional, future research is needed to establish if different ways of thinking about and managing diabetes and depression can predict patient outcome. Conclusions: The DDRMQ is the first measure of patient understanding, management and medication beliefs in people with established diagnoses of both diabetes and depression. The DDRMQ will facilitate an increased awareness of the patient experience of diabetes and depression and help inform patient centred care and intervention development for people with multiple conditions. (C) 2014 Elsevier B.V. All rights reserved
引用
收藏
页码:192 / 200
页数:9
相关论文